Türkiye’s competitors watchdog Thursday introduced it had launched an investigation into 19 pharmaceutical firms to find out whether or not they had violated competitors regulation.
In a press release, the Competition Authority (RK) mentioned it had selected Nov. 9 to launch the probe into firms together with AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Bausch & Lomb, Sanofi and Pfizer. It offered no additional particulars.
Asked in regards to the matter, AstraZeneca mentioned it doesn’t touch upon ongoing investigations as a matter of coverage, Reuters reported.
GlaxoSmithKline, Sanofi and Germany’s Merck KGaA all mentioned they had been absolutely cooperating with competitors authorities in Türkiye, however didn’t elaborate additional.
In a press release, BASF mentioned it was assessing the matter and was dedicated to excessive requirements of authorized compliance and business ethics.
AbbVie, Abdi Ibrahim, Bausch & Lomb, Bayer, Ilko, Johnson & Johnson, Liba, Menarini, Michael Page International, Panasonic, Pfizer, SIFI and World Medicine couldn’t instantly be reached for remark.
Source: www.dailysabah.com